Characterization of 89Zr-trastuzumab for clinical HER2 immunoPET imaging

被引：0
|
作者：
Dijkers, E.
Lub-de Hooge, M. N.
Kosterink, J. G.
Jager, P. L.
Brouwers, A. H.
Perk, L. R.
van Dongen, G. A.
de Vries, E. G.
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3508
引用
收藏
页数：1
相关论文
共 50 条
  • [41] 89Zr-ImmunoPET companion diagnostics and their impact in clinical drug development
    McKnight, Brooke N.
    Viola-Villegas, Nerissa T.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (09): : 727 - 738
  • [42] CYCLOTRON-DERIVED LONG-LIVED RADIOMETAL PET ISOTOPE 89ZR: CONJUGATION TO TRASTUZUMAB FOR PRECLINICAL IMMUNOPET IMAGING STUDIES
    Price, R.
    Scharli, R.
    Chan, S.
    Jeffery, C.
    Asad, A.
    Morandeau, L.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 47 - 48
  • [43] Use of total HER2 and HER2 homodimer levels to predict response to trastuzumab
    Leitzel, K.
    Lipton, A.
    Koestler, W.
    Fuchs, E.
    Ali, S. M.
    Weidler, J.
    Wu, Y.
    Sperinde, J.
    Huang, W.
    Bates, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] 18F-FDG, 18F-4FMFES, and 89Zr-trastuzumab PET imaging protocol in a preclinical breast cancer model
    Paquette, Michel
    Beaudoin, Simon
    Phoenix, Serge
    Fafard-Couture, Laurent
    Lecomte, Roger
    Guerin, Brigitte
    Turcotte, Aric
    Leyton, Jeff
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [45] Design and efficient synthesis of a bifunctional octadentate ligand for immunoPET imaging with Zr-89
    Abdalrahman, Mahmoud
    Planalp, Roy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [46] Ga-68 labeled Trastuzumab Fab for imaging HER2 positive lesions: formulation and characterization.
    Rathore, Yogesh
    Shukla, Jaya
    Bhusari, Priya
    Singh, Shashank Shekhar
    Chhabra, Anupriya
    Singh, Gurpreet
    Mittal, Bhagwant
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [47] Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice
    Tinianow, Jeff N.
    Pandya, Darpan N.
    Pailloux, Sylvie L.
    Ogasawara, Annie
    Vanderbilt, Alexander N.
    Gill, Herman S.
    Williams, Simon-P.
    Wadas, Thaddeus J.
    Magda, Darren
    Marik, Jan
    THERANOSTICS, 2016, 6 (04): : 511 - 521
  • [48] Imaging the LAT-1 amino acid transporter with Zr-89 immunoPET
    Ikotun, Oluwatayo
    Zheleznyak, Alex
    Masuko, Takashi
    McConathy, Jonathan
    Lapi, Suzanne
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [49] Dual targeting of HER2 with lapatinib and trastuzumab
    Joensuu, Heikki
    LANCET ONCOLOGY, 2014, 15 (10): : 1050 - 1052
  • [50] SITE-SPECIFICALLY 89ZR-RADIOLABELED MONOCLONAL ANTIBODIES FOR IMMUNOPET IMAGING
    Tinianow, J.
    Gill, H.
    Ogasawara, A.
    Flores, J.
    Vanderbilt, A.
    Raab, H.
    Vandlen, R.
    Williams, S.
    Marik, J.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S99 - S99
12345